Enjaymo Marks Latest Milestone In Sanofi’s Blood Disorder Effort

 
• By Alaric DeArment
  
3-D Rendering Red Blood Cells
Sanofi won approval for Enjaymo in cold agglutinin disease • Source: Shutterstock

More from New Products

More from Scrip